Literature DB >> 6621518

Regulation of expression of genes for enzymes of the mammalian urea cycle in permanent cell-culture lines of hepatic and non-hepatic origin.

D F Haggerty, E B Spector, M Lynch, R Kern, L B Frank, S D Cederbaum.   

Abstract

We present here the results of investigations conducted by ourselves and others on the regulation of the expression of genes encoding the enzymes of the mammalian urea cycle as manifest in cultured cells of both hepatic and extrahepatic origin. Upon consideration of the recently discovered discrete non-hepatic arginase genetic locus in man and our consequent hypothesis that the form of arginase thus transcribed in such extrahepatic cells functions principally in providing ornithine for protein anabolism and polyamine biosynthesis, rather than in detoxifying ammonia through urea formation, we have chosen instead to study permanent cell lines that are derived from liver and continue to perform a variety of hepatic functions in culture as experimental models for probing the molecular mechanisms underlying the control of ureagenesis within the mature liver cell. Of two such arginase-positive rat-hepatoma lines, we have characterized extensively in one (H4-II-E-C3) the mode of action of glucocorticoids in augmenting the cellular levels of this enzyme as well as of argininosuccinate synthetase. To this end, we have recently demonstrated that these stimulations are both mediated by binding of the hormones to classical cytoplasmic steroid receptors in a specific and saturable fashion and have thus concluded that the H4-II-E-C3 line will provide a suitable cell culture system for subsequent more detailed experiments from which the information garnered will continue to be relevant to the ureagenic pathway as modulated in the differentiated hepatocyte in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6621518     DOI: 10.1007/bf00225246

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  69 in total

1.  ENZYMES OF ARGININE METABOLISM IN MAMMALIAN CELL CULTURE. I. REPRESSION OF ARGININOSUCCINATE SYNTHETASE AND ARGININOSUCCINASE.

Authors:  R T SCHIMKE
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Repression of enzymes of arginine biosynthesis in mammalian tissue culture.

Authors:  R T SCHIMKE
Journal:  Biochim Biophys Acta       Date:  1962-08-27

3.  Types of arginase in rat tissues.

Authors:  P K Reddi; W E Knox; A Herzfeld
Journal:  Enzyme       Date:  1975

4.  Studies of cAMP metabolism in cultured hepatoma cells: presence of functional adenylate cyclase despite low cAMP content and lack of hormonal responsiveness.

Authors:  B H Leichtling; Y F Su; J Wimalasena; T K Harden; B B Wolfe; W D Wicks
Journal:  J Cell Physiol       Date:  1978-08       Impact factor: 6.384

5.  Rates of albumin and transferrin synthesis in vitro in rat hepatoma-derived H4II-EC cells.

Authors:  S H Ohanian; S B Taubman; G J Thorbecke
Journal:  J Natl Cancer Inst       Date:  1969-08       Impact factor: 13.506

6.  Dedifferentiated variants of a rat hepatoma: analysis by cell hybridization.

Authors:  J Deschatrette; E E Moore; M Dubois; D Cassio; M C Weiss
Journal:  Somatic Cell Genet       Date:  1979-11

7.  Dietary and hormonal regulation of urea cycle enzymes in rat liver.

Authors:  D Christowitz; F J Mattheyse; J B Balinsky
Journal:  Enzyme       Date:  1981

8.  Control of argininosuccinate synthetase by arginine in human lymphoblasts.

Authors:  J D Irr; L B Jacoby
Journal:  Somatic Cell Genet       Date:  1978-01

9.  Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.

Authors:  J Dancis; L C Yip; R P Cox; S Piomelli; M E Balis
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans.

Authors:  L D Brebnor; J Grimm; J B Balinsky
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.